Skip to main content
CivicGate

HB 1158 IN

Breakthrough therapies.

IN · session 2023 · Assembly / House · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 10, 2023

Latest action (Feb 13, 2023) Representatives Lucas and Miller K added as coauthors

Summary

Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.

Sponsor (1)
2 coauthors / cosponsors

Action history (3)
  1. Jan 10, 2023 Authored by Representative Moed · lower
  2. Jan 10, 2023 First reading: referred to Committee on Public Health · lower
  3. Feb 13, 2023 Representatives Lucas and Miller K added as coauthors · lower
Subjects
DRUGS AND MEDICINESFOODS; FOOD AND BEVERAGE TAXESHEALTH, Disease ControlHEALTH, Health Care Professionals

Text versions (1)

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

  • Introduced House Bill (H) · Jan 9, 2023 · PDF

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →